Article title: Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
Authors: Blanco G, Vardi A, Puiggros A, Gómez- Llonín A, Muro M, Rodríguez-Rivera M, Stalika E, Abella E, Gimeno E, López-Sánchez M, et al.
Journal: Oncoimmunology
Bibliometrics: Volume 7, Number 6, pages e1432328-1–e1432328-9
DOI: http://dx.doi.org/10.1080/2162402X.2018.1432328
When this article was first published online, there were some data errors in the first paragraph of the Introduction section. These have now been corrected and republished. The revised paragraph is as follows:
Clinical CLL-like monoclonal B cell lymphocytosis (MBL) is characterized by the presence of a clonal population of B lymphocytes in the peripheral blood (0.5 to <5 x 109/L) having a phenotype consistent with chronic lymphocytic leukemia (CLL). It is an asymptomatic condition, yet considered to be a premalignant precursor of CLL, with a progression rate of 1.1% per year to CLL requiring therapy. In fact, the great majority of CLL are preceded by an MBL stage.1–3 Therefore, the study of MBL is critical to understand CLL ontogenesis and clinical evolution.